FindTrial
Sign In

Study to identify the causes for liver fibrosis in psoriasis

Association of risk factors for liver fibrosis in psoriasis detected by Transient Elastography: A case control study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/059898
Enrollment
84
Registered
2023-11-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

Dr Susanna Thresia Joseph
Lead Sponsor
Indian Association of Dermatologist Venereologists and Leprologists
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All psoriasis patients attending the Dermatology OPD at AIMS during the study period.

Exclusion criteria

Exclusion criteria: 1 All patients who are known cases of chronic liver disease due to other causes. 2. All alcoholic patients. 3. Patients lost to follow-up 4. Not willing for study

Design outcomes

Primary

MeasureTime frame
Liver Involvement in psoriasis patients is more likely to be associated with metabolic syndromeTimepoint: 18 months—

Secondary

MeasureTime frame
Incremental Cost Effectiveness RatioTimepoint: 18 months—

Countries

India

Contacts

Public ContactDr Susanna Thresia Joseph

Amrita Institute of Medical Sciences

vinithavpanicker@aims.amrita.edu9847179964

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026